Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.

ABSTRACT:

Objectives

To evaluate the role of short-term low-dose glucocorticoids in mild COVID-19 patients.

Methods

We conducted a retrospective, cross-sectional, single-center study in Kunming, China. A total of 33 mild COVID-19 cases were divided into two treatment groups (with and without glucocorticoids, methylprednisolone, were used in this setting), and the absolute value of peripheral blood lymphocyte count; CD3+, CD4+, and CD8+ T cell counts; and the time to achieve negative transformation of a nucleic acid pharyngeal swab were recorded. Peripheral blood lymphocyte and T cell counts were compared between the treatment group and 25 healthy individuals. At the point of time when there was a 50% accumulation conversion rate (positive to negative nucleic acid on pharyngeal swab),

SUBMITTER: Fu HY 

PROVIDER: S-EPMC7519460 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature